+1 (202) 780-3397
A Look at placental tissue allografts in wound healing and musculoskeletal injuries: Protocols for successful outcomes
Joint Event on 2nd Global Summit on Dermatology and Cosmetology & 3rd International Conference on Wound Care, Tissue Repair and Regenerative Medicine
September 09-10, 2019 | Edinburgh, Scotland
Bruce Werber
BioStem Life Sciences, USA
Posters & Accepted Abstracts : Dermatol Res Skin Care
Abstract:
Musculoskeletal trauma and wound healing acceleration
utilizing Rheo, a cryopreserved amniotic fluid,
Wharton’s jelly, Extra-Cellular Matrix (ECM) allograft,
minimally manipulated via the AnuSureTech proprietary
process.
Maintaining the functionality of healthy placental tissue
containing extracellular matrix and bioactive cytokines
(growth factors, chemokines), intracellular messengers
(miRNA, Exosomes) and cellular components in a
cryopreserved injectable allograft. It is the combination of
the amniotic fluid, cellular components, Wharton’s jelly,
ECM, cytokines producing a immunomodulatory, and antiinflammatory
effect. That enhances the recipients, tissue
regenerative ability and providing significant value in pain
control, orthopedic pathologies, organ system pathologies.
The bioassay results presented in this paper demonstrate
that the AnuSureTech process is a significant advancement in
placental tissue processing providing high levels of cytokines,
growth factors, cellular components and ECM after processing
and sterilization.
Case study discussion of specific protocols to utilize this
regenerative allograft in order to achieve optimal success
in a variety of orthopedic, wound and cosmetic indications.
Allowing their use in regenerative medicine highly effective
and safe.
Biography:
E-mail:
docwerber@gmail.comPDF HTML